
|Articles|March 15, 2002
- BioPharm International-03-15-2002
- Volume 15
- Issue 3
The Importance of Freezing on Lyophilization Cycle Development
Author(s)Thomas W. Patapoff, David E. Overcashier
by Thomas W. Patapoff and David E. Overcashier Genentech, Inc. The freezing method used during lyophilization can substantially affect the structure of the ice formed, the water-vapor flow during primary drying, and the quality of the final product. Controlling how a solution freezes can shorten lyophilization cycles and produce more stable formations.
Advertisement
Articles in this issue
almost 24 years ago
Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?almost 24 years ago
Guest Editorial: Warning Letters ? A Symptom?almost 24 years ago
Business Benefits of Computer Systems Validationalmost 24 years ago
A System Developer's Approach to ValidationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5




